362 related articles for article (PubMed ID: 10774817)
61. Monoclonal antibody characterization of progesterone receptors, estrogen receptors and the stress-responsive protein of 27 kDa (SRP27) in human uterine leiomyoma.
Navarro D; Cabrera JJ; Falcón O; Jiménez P; Ruiz A; Chirino R; López A; Rivero JF; Díaz-Chico JC; Díaz-Chico BN
J Steroid Biochem; 1989; 34(1-6):491-8. PubMed ID: 2626044
[TBL] [Abstract][Full Text] [Related]
62. Oxytocin-induced cell growth proliferation in human myometrial cells and leiomyomas.
Busnelli M; Rimoldi V; Viganò P; Persani L; Di Blasio AM; Chini B
Fertil Steril; 2010 Oct; 94(5):1869-74. PubMed ID: 20056210
[TBL] [Abstract][Full Text] [Related]
63. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P
Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
[TBL] [Abstract][Full Text] [Related]
64. Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat.
Burroughs KD; Fuchs-Young R; Davis B; Walker CL
Biol Reprod; 2000 Nov; 63(5):1322-30. PubMed ID: 11058535
[TBL] [Abstract][Full Text] [Related]
65. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
66. Transforming growth interacting factor expression in leiomyoma compared with myometrium.
Yen-Ping Ho J; Man WC; Wen Y; Polan ML; Shih-Chu Ho E; Chen B
Fertil Steril; 2010 Aug; 94(3):1078-83. PubMed ID: 19524896
[TBL] [Abstract][Full Text] [Related]
67. Oestrogen and progesterone receptor concentrations in leiomyoma and normal myometrium.
Sadan O; van Iddekinge B; van Gelderen CJ; Savage N; Becker PJ; van der Walt LA; Robinson M
Ann Clin Biochem; 1987 May; 24 ( Pt 3)():263-7. PubMed ID: 3606010
[TBL] [Abstract][Full Text] [Related]
68. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth.
Yoshida S; Ohara N; Xu Q; Chen W; Wang J; Nakabayashi K; Sasaki H; Morikawa A; Maruo T
Semin Reprod Med; 2010 May; 28(3):260-73. PubMed ID: 20414849
[TBL] [Abstract][Full Text] [Related]
69. Treatment effects of GnRH agonist on the binding of estrogen and progesterone, and the histological findings of uterine leiomyomas.
Uemura T; Mori J; Yoshimura Y; Minaguchi H
Asia Oceania J Obstet Gynaecol; 1991 Dec; 17(4):315-20. PubMed ID: 1724899
[TBL] [Abstract][Full Text] [Related]
70. Dysregulation of IGF-I signaling in uterine leiomyoma.
Burroughs KD; Howe SR; Okubo Y; Fuchs-Young R; LeRoith D; Walker CL
J Endocrinol; 2002 Jan; 172(1):83-93. PubMed ID: 11786376
[TBL] [Abstract][Full Text] [Related]
71. Estrogen responses in bovine fetal uterine cells involve pathways directed by both estrogen response element and activator protein-1.
Malayer JR; Cheng J; Woods VM
Biol Reprod; 1999 May; 60(5):1204-10. PubMed ID: 10208985
[TBL] [Abstract][Full Text] [Related]
72. The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells.
Soto AM; Chung KL; Sonnenschein C
Environ Health Perspect; 1994 Apr; 102(4):380-3. PubMed ID: 7925178
[TBL] [Abstract][Full Text] [Related]
73. Influence of exogenous estrogen receptor ligands on uterine leiomyoma: evidence from an in vitro/in vivo animal model for uterine fibroids.
Hunter DS; Hodges LC; Eagon PK; Vonier PM; Fuchs-Young R; Bergerson JS; Walker CL
Environ Health Perspect; 2000 Oct; 108 Suppl 5():829-34. PubMed ID: 11035990
[TBL] [Abstract][Full Text] [Related]
74. Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma.
Walker CL
Recent Prog Horm Res; 2002; 57():277-94. PubMed ID: 12017548
[TBL] [Abstract][Full Text] [Related]
75. Down-regulation and gene hypermethylation of the 14-3-3 gamma in uterine leiomyoma.
Jiang W; Luo H; Shen Z; Zhang W; Chen A; Zhu X
Front Biosci (Landmark Ed); 2016 Jun; 21(6):1286-95. PubMed ID: 27100507
[TBL] [Abstract][Full Text] [Related]
76. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.
Al-Hendy A; Salama SA
J Soc Gynecol Investig; 2006 Feb; 13(2):136-44. PubMed ID: 16443508
[TBL] [Abstract][Full Text] [Related]
77. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
Vu K; Greenspan DL; Wu TC; Zacur HA; Kurman RJ
Hum Pathol; 1998 Apr; 29(4):359-63. PubMed ID: 9563785
[TBL] [Abstract][Full Text] [Related]
78. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells.
Al-Hendy A; Diamond MP; El-Sohemy A; Halder SK
J Clin Endocrinol Metab; 2015 Apr; 100(4):E572-82. PubMed ID: 25625804
[TBL] [Abstract][Full Text] [Related]
79. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
[TBL] [Abstract][Full Text] [Related]
80. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
